These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35886862)

  • 41. Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with α2-gliadin or gluten.
    Engström N; Sandberg AS; Scheers N
    Nutrients; 2015 Mar; 7(4):2134-44. PubMed ID: 25816160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intestinal anti-tissue transglutaminase IgA deposits as a complementary method for the diagnostic evaluation of celiac disease in patients with low-grade histological lesions.
    Roca M; Donat E; Masip E; Ballester V; Gómez I; SanFelix M; Ramos D; Calvo-Lerma J; Giner-Pérez L; Bolonio M; Polo B; Ribes-Koninckx C
    Clin Exp Immunol; 2022 May; 207(3):279-286. PubMed ID: 35553627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peculiar Ca
    Sposito S; Secondo A; Romanelli AM; Montefusco A; Nanayakkara M; Auricchio S; Barone MV; Caputo I; Paolella G
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
    Borrelli M; Maglio M; Korponay-Szabó IR; Vass V; Mearin ML; Meijer C; Niv-Drori H; Ribes-Koninckx C; Roca M; Shamir R; Troncone R; Auricchio R
    Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.
    Mamone G; Camarca A; Fierro O; Sidney J; Mazzarella G; Addeo F; Auricchio S; Troncone R; Sette A; Gianfrani C
    J Agric Food Chem; 2013 Jan; 61(3):747-54. PubMed ID: 23244345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.
    Di Niro R; Snir O; Kaukinen K; Yaari G; Lundin KE; Gupta NT; Kleinstein SH; Cols M; Cerutti A; Mäki M; Shlomchik MJ; Sollid LM
    Mucosal Immunol; 2016 Jan; 9(1):254-64. PubMed ID: 26153762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.
    Rauhavirta T; Oittinen M; Kivistö R; Männistö PT; Garcia-Horsman JA; Wang Z; Griffin M; Mäki M; Kaukinen K; Lindfors K
    J Clin Immunol; 2013 Jan; 33(1):134-42. PubMed ID: 22878839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis.
    Myrsky E; Kaukinen K; Syrjänen M; Korponay-Szabó IR; Mäki M; Lindfors K
    Clin Exp Immunol; 2008 Apr; 152(1):111-9. PubMed ID: 18279443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detoxification of gluten by means of enzymatic treatment.
    Wieser H; Koehler P
    J AOAC Int; 2012; 95(2):356-63. PubMed ID: 22649919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
    Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
    Stenberg P; Roth B; Wollheim FA
    Eur J Intern Med; 2009 Dec; 20(8):749-55. PubMed ID: 19892302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.
    Dotsenko V; Tewes B; Hils M; Pasternack R; Isola J; Taavela J; Popp A; Sarin J; Huhtala H; Hiltunen P; Zimmermann T; Mohrbacher R; Greinwald R; Lundin KEA; Schuppan D; Mäki M; Viiri K;
    Nat Immunol; 2024 Jul; 25(7):1218-1230. PubMed ID: 38914866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential Celiac Disease in Children: Health Status on A Long-Term Gluten-Containing Diet.
    Mandile R; Lerro F; Carpinelli M; D'Antonio L; Greco L; Troncone R; Auricchio R
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transglutaminase and the pathogenesis of coeliac disease.
    Stenberg P; Roth EB; Sjöberg K
    Eur J Intern Med; 2008 Mar; 19(2):83-91. PubMed ID: 18249302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.
    Adriaanse MP; Leffler DA; Kelly CP; Schuppan D; Najarian RM; Goldsmith JD; Buurman WA; Vreugdenhil AC
    Am J Gastroenterol; 2016 Jul; 111(7):1014-22. PubMed ID: 27185075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of transglutaminase 2 in celiac disease pathogenesis.
    Klöck C; Diraimondo TR; Khosla C
    Semin Immunopathol; 2012 Jul; 34(4):513-22. PubMed ID: 22437759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies and CD: past and future of celiac antibody testing.
    Korponay-Szabó IR
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S11-3. PubMed ID: 24979192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.